03 Oct, 2014
HyTest receives Achiever Certificate 2014
Companies receiving Achiever certification are stable businesses with solid growth, good financial results and profitability.
Read more
16 Sep, 2014
HyTest’s 20th anniversary year starts with strong growth in sales
During the first half of the year, HyTest’s consolidated sales were 7.8 million euros and year-on-year sales grew by 24%. Group operating profit also saw significant growth, reaching 3.4 million euros.
Read more
09 Jul, 2014
HyTest will be attending AACC 2014 in Chicago on July 29-31
HyTest participates in AACC 2014 Clinical Lab Expo Exhibition in Chicago on July 29-31. You are welcome to visit our booth #3631at any time. Our team is looking forward to see you there!
Read more
27 May, 2014
HyTest attends ISACP in Copenhagen
HyTest will be present at ISACP 2014 Veterinary Conference. The ISACP will be held on 25-29 of June 2014 in Copenhagen, Denmark.
Read more
11 Apr, 2014
HyTest fiscal year 2013 - a record level of operating profit
HyTest turns 20 and reaches a record level of operating profit. While the previous year’s growth figures were not achieved, sales grew steadily throughout the fiscal year.
Read more
26 Jan, 2014
HyTest attends IVD Summit and CACLP in China
This March HyTest will be present at this year’s IVD summit and CACLP exhibition. The 11th CACLP exhibition will be held on 5-7 March in Hefei and the 5th IVD Summit will be held in Xiamen on 8-9 March.
Read more
11 Dec, 2013
Mercodia commercializes HyTest's proprietary IGFBP-4 fragments technology
Mercodia commercializes HyTest's proprietary IGFBP-4 fragments technology; A novel risk marker for cardiovascular disease
Read more
04 Dec, 2013
Affinity Life Sciences to commercialize HyTest’s proprietary SES-BNP™ technology
HyTest and Affinity Life Sciences (AFF) have signed a licensing agreement that allows AFF to develop and commercialize a research use only ELISA-kit based on HyTest’s proprietary SES-BNP™ technology.
Read more
24 Oct, 2013
HyTest participates in NextDx EU-funded consortium to develop new highly sensitive blood testing technology
eading companies and institutes in protein diagnostics and micro-nano-bio research, including Philips, imec, Hytest, PolyAn, Bremen University and Eindhoven University of Technology, have joined forces
Read more
16 Oct, 2013
HyTest attending Medica trade fair in November 2013
HyTest participates in Medica exhibition in November 20th - 23rd. Welcome to visit our booth D64 in hall three at any time.
Read more
13 Jul, 2013
Meet Us at AACC Houston
It's again time for AACC. This time Houston will be the place where the world of laboratory medicine will come together.
Read more
18 Jun, 2013
Half-year Financial Report
Over the past half-year, HyTest consolidated sales amounted to EUR 6.3 million.
Read more
13 May, 2013
HyTest anti-cTnI antibodies utilized in a novel, highly sensitive cTnI assay
LamdaGen’s new diagnostic platform allows rapid and reproducible quantification of cTnI from whole serum.
Read more
05 May, 2013
HyTest awarded an Achiever Certificate
A company’s strong financial position shows that partnerships can be built on a solid foundation and can withstand economic fluctuations.”
Read more
28 Nov, 2012
Monoclonal antibody to glycated hemoglobin (HbA1c)
Diabetes causes substantial health costs because of complications associated with it and therefore repeated glucose measurements are an essential part of diabetes daily care.
Read more
04 Nov, 2012
HyTest attends to MEDICA 2012 in Düsseldorf in November
HyTest attends to MEDICA 2012 in Düsseldorf in November. You are warmly welcome to pass by at our booth # 3D64 .
Read more
21 May, 2012
HyTest excellent half year growth
Year to year revenue growth was 18%. Hytest profitability continues to be on high level even though HyTest has been investing to China operations and IP-portfolio amongst other things.
Read more
10 Jan, 2012
HyTest’s strong growth continues
HyTest’s revenue at the end of October for the fiscal year 2010-2011 year was EUR 10.2 million. HyTest was again capable of growing its market share as growth over the previous year was 12% which exceeds the industry average.
Read more
21 Jun, 2011
HyTest abstract has won National Academy of Clinical Biochemistry Distinguished Abstract Award
HyTest attends to AACC 2011 Clinical Expo in Atlanta, July 25-28. You are warmly welcome to visit our booth #27 at any time.
Read more

Sign up to our newsletter

And be informed about new products and scientific findings

Thank you for your subscription!